Insigna, Inc.
Champaign, IL Doing business as Epivara, Inc.
- UEI
- JGXWKCJNGZ15
- CAGE
- 8BNA4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2109 S Oak St #100a, Champaign, IL 61820, USA
- Website
- epivara.com
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Most male piglets raised for pork in the united states are surgically castrated during their first week of life to… | Institute of Food Production and Sustainability | $650,000 | |
| Sbir phase i: safe non-surgical alternative to spays in female cats -the broader impact of this small business… | National Science Foundation | $275,000 | |
| Surgical castration of newborn pigs is used to prevent aggression as the male age during the grow-out period and to… | Institute of Food Production and Sustainability | $175,000 | |
| Sbir phase i: safe and effective injectable alternative to surgical spays in female dogs | Division of Industrial Innovation | $254,760 |
About Insigna, Inc.
Insigna, Inc., doing business as Epivara, Inc., is a minority-owned, for-profit corporate entity registered in SAM.gov that specializes in developing innovative biotechnology solutions for animal reproductive health and sterilization. The company focuses on creating non-surgical alternative methods for animal population control, with a particular emphasis on developing injectable sterilization technologies for different animal species. Registered since May 20, 2019, with an active SAM.gov registration until March 5, 2025, the company has positioned itself as a research-driven organization targeting critical challenges in veterinary medicine and animal welfare.
The company has consistently secured federal grants from civilian agencies, primarily the National Science Foundation (NSF), to advance its research in non-surgical sterilization techniques. Epivara has received multiple Project Grants targeting innovative solutions for different animal species, including a $275,000 NSF grant to develop a non-surgical sterilization method for female cats, a $254,760 grant to create an injectable alternative to surgical spays for female dogs, and a grant focused on developing a solution for surgical castration of newborn pigs. These grants, awarded through programs like NSF Technology, Innovation, and Partnerships and the Division of Industrial Innovation, demonstrate the company's commitment to developing minimally invasive reproductive control methods that address animal welfare concerns, reduce surgical risks, and provide more humane and cost-effective alternatives to traditional veterinary sterilization procedures.
Quick answers
What is Insigna, Inc.'s UEI?
Insigna, Inc.'s Unique Entity ID (UEI) in SAM.gov is JGXWKCJNGZ15.
What is Insigna, Inc.'s CAGE code?
Insigna, Inc.'s CAGE code is 8BNA4.
Where is Insigna, Inc. located?
Insigna, Inc.'s physical address in SAM.gov is 2109 S Oak St #100a, Champaign, IL 61820, USA.
Is Insigna, Inc. registered in SAM.gov?
Yes. Insigna, Inc.'s SAM.gov registration is active through February 1, 2027.
What is Insigna, Inc.'s most recent federal award?
Insigna, Inc.'s most recent federal grant award is Most male piglets raised for pork in the united states are surgically castrated during their first week of life to… (20263941046787), from Institute of Food Production and Sustainability, on September 1, 2026.
On GovTribe
See Insigna, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors